BioNTech SE

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.

About BNTX

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.

CEO

Ugur Sahin

CEOUgur Sahin

Employees

6,772

Employees6,772

Headquarters

Mainz, Rheinland-Pfalz

HeadquartersMainz, Rheinland-Pfalz

Founded

2008

Founded2008

Employees

6,772

Employees6,772

BNTX Key Statistics

Market cap

25.63B

Market cap25.63B

Price-Earnings ratio

-30.70

Price-Earnings ratio-30.70

Dividend yield

—

Dividend yield—

Average volume

1.67M

Average volume1.67M

High today

$107.70

High today$107.70

Low today

$105.12

Low today$105.12

Open price

$106.01

Open price$106.01

Volume

1.32M

Volume1.32M

52 Week high

$131.49

52 Week high$131.49

52 Week low

$76.53

52 Week low$76.53

BNTX News

Seeking Alpha 2d

BioNTech to buy German rival CureVac for $1.25B in all-stock deal

BioNTech (NASDAQ:BNTX) has agreed to acquire its German rival CureVac (NASDAQ:CVAC) in an all-stock transaction worth nearly $1.25B, the companies announced Thu...

Analyst ratings

76%

of 25 ratings

Buy

76%

Hold

24%

Sell